Luis Fernández Selected Research

Luis Fernández Research Topics

2	Neoplasms (Cancer) 01/2022 - 11/2017
2	COVID-19 11/2021 - 01/2020
2	Glioblastoma (Glioblastoma Multiforme) 01/2021 - 12/2020
2	DiGeorge Syndrome (Syndrome, DiGeorge) 01/2020 - 06/2009
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2022
1	Infections 11/2021
1	Prostatic Neoplasms (Prostate Cancer) 01/2021
1	Hypoxia (Hypoxemia) 12/2020
1	Wounds and Injuries (Trauma) 01/2019
1	Polyuria 01/2019
1	Critical Illness (Critically Ill) 01/2019
1	Nephrogenic Diabetes Insipidus 01/2019
1	Colorectal Neoplasms (Colorectal Cancer) 11/2017
1	Adenocarcinoma 11/2017
1	Inborn Genetic Diseases (Disease, Hereditary) 08/2013
1	Intellectual Disability (Idiocy) 08/2013
1	Beckwith-Wiedemann Syndrome (Exomphalos Macroglossia Gigantism Syndrome) 11/2012
1	Chromosome Duplication 11/2012
1	Chromosome Aberrations (Chromosome Abnormalities) 03/2012
1	Ulcerative Colitis 12/2010
1	Cleft Lip (Harelip) 06/2009
1	Hemorrhage 06/2009

2	Biological ProductsIBA 01/2021 - 12/2020
1	TetraspaninsIBA 01/2022
1	Complement System Proteins (Complement)IBA 01/2022
1	anti-IgGIBA 11/2021
1	Immunoglobulin G (IgG)IBA 11/2021
1	AntibodiesIBA 11/2021
1	Pharmaceutical PreparationsIBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	Interleukin-6 (Interleukin 6)IBA 01/2020
1	beta-cyclodextrin tetradecasulfate (CTDS)IBA 01/2020
1	C-Reactive ProteinIBA 01/2020
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2020
1	Arginine Vasopressin (Argipressin)IBA 01/2019
1	GoldIBA 11/2017
1	Proteins (Proteins, Gene)FDA Link 11/2017
1	Type I Tumor Necrosis Factor ReceptorsIBA 11/2017
1	OligonucleotidesIBA 08/2013
1	SilverIBA 11/2012
1	SteroidsIBA 12/2010
1	Beclomethasone (Beclometasone)FDA Link 12/2010
1	A 7 (A-7)IBA 06/2009
1	Aprotinin (Trasylol)FDA Link 06/2009

1	Therapeutics 01/2021
1	Precision Medicine 01/2021
1	Drug Therapy (Chemotherapy) 01/2021
1	Lab-On-A-Chip Devices 12/2020
1	Negative-Pressure Wound Therapy 01/2019
1	Ligation 03/2012
1	Blood Transfusion (Blood Transfusions) 06/2009